Related Experiment Video
Updated: Jul 15, 2026

Transuterine Fetal Tracheal Occlusion Model in Mice
Published on: February 5, 2021
Congenital diaphragmatic hernia (CDH) etiology as revealed by pathway genetics
Sibel Kantarci1, Patricia K Donahoe
1Peadiatric Surgical Research Laboratories at Massachusetts General Hospital, Boston, MA 02114, USA.
Insights
This study identifies critical chromosomal regions and genes linked to congenital diaphragmatic hernia (CDH), a severe birth defect. Understanding these genetic pathways may lead to new treatment strategies for CDH patients.
Area of Science:
- Genetics
- Developmental Biology
- Medical Genetics
Background:
- Congenital diaphragmatic hernia (CDH) is a significant birth defect associated with high mortality and morbidity.
- Understanding the genetic underpinnings of CDH is crucial for improving patient outcomes and developing targeted therapies.
Purpose of the Study:
- To identify critical chromosomal loci and genes involved in the development of congenital diaphragmatic hernia (CDH).
- To explore potential molecular pathways and genetic factors contributing to CDH pathogenesis.
- To lay the groundwork for novel therapeutic strategies by elucidating CDH-related genetic mechanisms.
Main Methods:
- Phenotypic classification of 270 CDH patients into isolated and complex cases.
- Candidate gene selection based on animal models, recurrent chromosomal aberrations (e.g., 15q26.1-q26.2, 1q41-q42.12), and developmental pathways (retinoic acid, embryonic lung development).
- Genetic analyses including linkage analysis, 10K SNP chip, microsatellite markers, array-based comparative genomic hybridization (aCGH), fluorescence in situ hybridization (FISH), and multiplex ligation-dependent probe amplification (MLPA).
Main Results:
- Identified a Donnai-Barrow syndrome (DBS) locus on chromosome 2q23.3-q31.1 in multiplex families with CDH.
- Detected a de novo microdeletion in a patient with Fryns syndrome associated with CDH using aCGH, further refined by FISH and MLPA.
- Highlighted the potential roles of genes like FOG2, GATA4, and COUP-TFII in a shared genetic and molecular pathway for diaphragm and lung development.
Conclusions:
- Genetic variations in specific chromosomal intervals contribute to the etiology of congenital diaphragmatic hernia.
- Elucidation of CDH-associated molecular pathways provides insights into developmental processes and potential therapeutic targets.
- Further research into these genetic pathways is essential for advancing the understanding and treatment of CDH.
Abstract:
Congenital diaphragmatic hernia (CDH) is a common birth defect with high mortality and morbidity. Two hundred seventy CDH patients were ascertained, carefully phenotyped, and classified as isolated (diaphragm defects alone) or complex (with additional anomalies) cases. We established different strategies to reveal CDH-critical chromosome loci and genes in humans. Candidate genes for sequencing analyses were selected from CDH animal models, genetic intervals of recurrent chromosomal aberration in humans, such as 15q26.1-q26.2 or 1q41-q42.12, as well as genes in the retinoic acid and related pathways and those known to be involved in embryonic lung development. For instance, FOG2, GATA4, and COUP-TFII are all needed for both normal diaphragm and lung development and are likely all in the same genetic and molecular pathway. Linkage analysis was applied first in a large inbred family and then in four multiplex families with Donnai-Barrow syndrome (DBS) associated with CDH. 10K SNP chip and microsatellite markers revealed a DBS locus on chromosome 2q23.3-q31.1. We applied array-based comparative genomic hybridization (aCGH) techniques to over 30, mostly complex, CDH patients and found a de novo microdeletion in a patient with Fryns syndrome related to CDH. Fluorescence in situ hybridization (FISH) and multiplex ligation-dependent probe amplification (MLPA) techniques allowed us to further define the deletion interval. Our aim is to identify genetic intervals and, in those, to prioritize genes that might reveal molecular pathways, mutations in any step of which, might contribute to the same phenotype. More important, the elucidation of pathways may ultimately provide clues to treatment strategies.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Hiatal Hernia
Hedgehog Signaling Pathway
